Update on HPV: Beyond cervical cancer

Presenters

	J.Thomas Cox, MD University of California Santa Barbarba Santa Barbara, California VIEW WEBCAST | TRANSCRIPT Click here for an exclusive recap from Dr Cox: HPV viruses and vaccines: FAQs to expect from patients
	Hope K. Haefner, MD University of Michigan Ann Arbor, Michigan VIEW WEBCAST | TRANSCRIPT Click here for an exclusive recap from Dr Haefner: HPV and the vulva and vagina
	Joel Palefsky, MD University of California Division of Infectious Diseases San Francisco, California VIEW WEBCAST | TRANSCRIPT Click here for an exclusive recap from Dr Palefsky: HPV in males

1.0 CME/CE Credits

Symposium held November 2008 at the American Society for Reproductive Medicine Annual Meeting in San Francisco, California. Supported by an independent educational grant from Merck and Co., Inc.

NEEDS ASSESSMENT

Clinicians have increasingly mastered knowledge of the natural history of human papillomavirus (HPV) in its association with cervical cancer, but generally remain less aware of the association of this virus in the etiology of many of the vaginal, vulvar, penile, anal, and oral pharyngeal cancers that occur in the US every year. In order address this knowledge gap this symposium is designed to provide a broad overview of all benign and malignant manifestations that occur secondary to infection with low- and high-risk HPV, and to discuss primary prevention through HPV vaccination.

LEARNING OBJECTIVES
At the end of this symposium, attendees will be able to:

1) Describe the mechanism of HPV-induced oncogenesis and the data to date on the prevention of cervical precancer (CIN3 and AIS) though HPV vaccination.
2) Discuss the burden of HPV associated cancers of the penis, anus and oral pharynx (including respiratory papillomatosis) and the data on primary prevention by HPV vaccination of HPV infection and precancer in these areas.
3) Describe the burden of HPV associated benign genital warts, vulvar intraepithelial neoplasia (VIN), vaginal intraepithelial neoplasia (VAIN) and cancers of the vulva and vagina and the data on primary prevention by HPV vaccination.

Click here to take the CME pretest

Click here to take the FREE CME/CE online.
1.0 CME/CE credit available
Start date: December 31, 2008
Expiration date: December 31, 2009

The American Society for Reproductive Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Society for Reproductive Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits.^TM

All speakers were required to complete a disclosure of commercial and financial relationships with manufacturers of pharmaceuticals, laboratory supplies, or medical devices and with commercial providers of medically related services. These disclosures were reviewed and potential conflicts of interest resolved by the Subcommittee on Standards of Commercial Support of the Continuing Medical Education Committee of the American Society for Reproductive Medicine. The disclosures are listed in the presentations.

Sexuality, Reproduction & Menopause © 2009 Quadrant HealthCom Inc.